Reducing antibiotic exposure in the NICU


Over the past decade, efforts to reduce unnecessary antibiotic use in the neonatal intensive care unit (NICU) have increased. A new report delivered results of a comprehensive quality improvement run in a level 4 NICU with the goal of decreasing antibiotic use by 20%

The investigators ran that initiative within the context of a multicenter learning collaborative that was focused on reducing the unnecessary use of antibiotics.

The strategies for improvement addressed the gaps seen in the core elements of antibiotic stewardship programs. Outcomes measured included the antibiotic use rate and the percentage of infants who were discharged without any exposure to antibiotics.

At the baseline of the quality initiative, the antibiotic use rate was 27.6% and it decreased to 15.5%, which was a 43% reduction in antibiotic use. The reduction was additionally maintained for >18 months.

The investigators said that changes that had the biggest effect on this decrease included a 36-hour hard stop for antibiotics, a novel guideline for early-onset sepsis evaluation among infants <35 weeks, implementing a sepsis risk calculator, and adopting a 36-hour rule-out period for sepsis evaluation.

During the quality initiative, the percent of infants who were discharged from the hospital without any exposure to antibiotics increased from 15.8% to 35.1%.

Additionally, the perfect of infants ≥ 36 weeks who underwent an evaluation for early-onset sepsis decreased by 42.3% and among infants < 35 weeks, it went down by 26%.

The researchers involved in the quality initiative concluded that it had led to a significant reduction in both antibiotic use and exposure in their neonatal intensive care unit.

They also believe that the comprehensive approach to the quality initiative could be useful to other teams that have a focus on improvement.

This article was originally published on Contemporary

Related Videos
raanan meyer, md
The importance of maternal vaccination | Image Credit:
Haywood Brown, MD | Image credit: © USF Health
image of interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.